| |
Abdominal
fat and what to do about it
(This article was first printed in the December
2006 issue of the Harvard Women’s
Health Watch. For more information or to
order, please go to http://www.health.harvard.edu/womens.)
Though the term might sound dated, “middle-age
spread” is a greater concern than ever.
As women go through their middle years, their
proportion of fat to body weight tends to increase — more
than it does in men. Especially at menopause,
extra pounds tend to park themselves around the
midsection, as the ratio of fat to lean tissue
shifts and fat storage begins favoring the upper
body over the hips and thighs. Even women who
don’t actually gain weight may still gain
inches at the waist.
At one time, women might have accepted these
changes as an inevitable fact of postmenopausal
life. But we’ve now been put on notice
that as our waistlines grow, so do our health
risks. Abdominal, or visceral, fat is of particular
concern because it’s a key player in a
variety of health problems — much more
so than subcutaneous fat, the kind you can grasp
with your hand. Visceral fat, on the other hand,
lies out of reach, deep within the abdominal
cavity, where it pads the spaces between our
abdominal organs.
Visceral fat has been linked to metabolic disturbances
and increased risk for cardiovascular disease
and type 2 diabetes. In women, it is also associated
with breast cancer and the need for gallbladder
surgery.
Abdominal
fat locations

Generally speaking, abdominal fat is either
visceral (surrounding the abdominal organs)
or subcutaneous (lying between the skin
and the abdominal wall). Fat located behind
the abdominal cavity, called retroperitoneal
fat, is generally counted as visceral fat.
Several studies indicate that visceral
fat is most strongly correlated with risk
factors such as insulin resistance, which
sets the stage for type 2 diabetes. Some
research suggests that the deeper layers
of subcutaneous fat may also be involved
in insulin resistance (in men but not in
women). |
Where’s the fat?
Fat accumulated in the lower body (the pear
shape) is subcutaneous, while fat in the abdominal
area (the apple shape) is largely visceral. Where
a woman’s fat ends up is influenced by
several factors. Heredity is one: Scientists
have identified a number of genes that help determine
how many fat cells an individual develops and
where these cells are stored (Proceedings
of the National Academy of Sciences, April
25, 2006). Hormones are also involved. At menopause,
estrogen production decreases and the ratio of
androgen (male hormones present in small amounts
in women) to estrogen increases — a shift
that’s been linked in some studies to increased
abdominal fat after menopause. Some researchers
suspect that the drop in estrogen levels at menopause
is also linked to increased levels of cortisol,
a stress hormone that promotes the accumulation
of abdominal fat.
As the evidence against abdominal fat mounts,
researchers and clinicians are trying to measure
it, correlate it with health risks, and monitor
changes that occur with age and overall weight
gain or loss. The most accurate measurement techniques,
magnetic resonance imaging and computed tomography,
are expensive and not available for routine use.
However, research using these imaging methods
has shown that waist circumference reflects abdominal
fat. It has largely superseded waist-to-hip ratio
(waist size divided by hip size) as an indicator
of fat distribution, because it is easier to
measure and about as accurate. There’s
also evidence that waist circumference is a better
predictor of health problems than body mass index
(BMI), which indicates only total body fat (see “Measuring
up”).
Measuring
up
Researchers have tried several ways
of measuring the links between health
risks and body weight or fat distribution:
Body mass index (BMI). A
ratio of weight in kilograms to the square
of height in meters, BMI helps identify
people whose weight increases their risk
for several conditions, including heart
disease, stroke, and diabetes. People with
BMIs of 25–29.9 are considered overweight,
and those with BMIs of 30 or over, obese.
However, some researchers think BMI isn’t
always a valid indication of obesity, because
it gives misleading results in people who
are very muscular or very tall. To calculate
your BMI, go to www.nhlbisupport.com/bmi or
use this formula: Weight in pounds × 703 ÷ (height
in inches)2.
Waist-to-hip ratio. To
find your waist-to-hip ratio, divide your
waist measurement at its narrowest point
by your hip measurement at its widest point.
As a marker of a person’s abdominal
fat, this measure outperforms BMI. For
women, the risk for heart disease and stroke
begins to rise at a ratio of about 0.8.
Waist circumference. The
simplest way to check for abdominal fat
is to measure your waist. Run a tape measure
around your torso at about the level of
your navel. (Official guidelines determine
the level at which waist circumference
is measured by locating a bony landmark:
the top of the right hipbone, or right
iliac crest, where it intersects a line
dropped vertically from the middle of the
right armpit.) Breathe minimally, and make
sure not to pull the tape measure so tight
that it depresses the skin. In women with
a BMI of 25–34.9, a waist circumference
greater than 35 inches is considered high
risk, although research suggests there
is some extra health risk at any size greater
than 33 inches. A study in the September
2006 American Journal of Clinical Nutrition found
that in women, a large waist was correlated
with diabetes risk — even when BMI
was in the normal range (18.5–24.9).
Since abdominal fat can be a problem despite
a normal BMI, health assessments should
include both BMI and waist circumference.
The relationship between waist circumference
and health risk varies by ethnic group.
For example, in Asian women, a waist circumference
above 31.5 inches is considered a health
risk. |
The good news is that visceral fat yields fairly
easily to exercise and diet, with benefits ranging
from lower blood pressure to more favorable cholesterol
levels. Subcutaneous fat located at the waist — the
pinchable stuff — can be frustratingly
difficult to budge, but in normal-weight people,
it’s generally not considered as much of
a health threat as visceral fat is. In fact,
a study published in the New England Journal
of Medicine in 2004 found that liposuction
removal of subcutaneous fat (up to 23 pounds
of it) in 15 obese women had no effect after
three months on their measures of blood pressure,
blood sugar, cholesterol, or response to insulin.
Weight loss through diet and exercise, on the
other hand, triggers many changes that have positive
health effects.
What’s wrong with abdominal fat?
Body fat, or adipose tissue, was once regarded
as little more than a storage depot for fat blobs
waiting passively to be used for energy. But
research suggests that fat cells — particularly
abdominal fat cells — are biologically
active. It’s more accurate to think of
fat as an endocrine organ or gland, producing
hormones and other substances that can profoundly
affect our health. One such hormone is leptin,
which is normally released after a meal and dampens
appetite. Fat cells also produce the hormone
adiponectin, which is thought to influence the
response of cells to insulin. Although scientists
are still deciphering the roles of individual
hormones, it’s becoming clear that excess
body fat, especially abdominal fat, disrupts
the normal balance and functioning of these hormones.
Scientists are also learning that visceral fat
pumps out immune system chemicals called cytokines — for
example, tumor necrosis factor and interleukin-6 — that
can increase the risk of cardiovascular disease
by promoting insulin resistance and low-level
chronic inflammation. These and other biochemicals,
some not yet identified, are thought to have
deleterious effects on cells’ sensitivity
to insulin, blood pressure, and blood clotting.
One reason excess visceral fat is so harmful
could be its location near the portal vein, which
carries blood from the intestinal area to the
liver. Substances released by visceral fat, including
free fatty acids, enter the portal vein and travel
to the liver, where they can influence the production
of blood lipids. Visceral fat is directly linked
with higher total cholesterol and LDL (bad) cholesterol,
lower HDL (good) cholesterol, and insulin resistance.
Insulin resistance means that your body’s
muscle and liver cells don’t respond adequately
to normal levels of insulin, the pancreatic hormone
that carries glucose into the body’s cells.
Glucose levels in the blood rise, heightening
the risk for diabetes. Together, insulin resistance,
high blood glucose, excess abdominal fat, unfavorable
cholesterol levels (including high triglycerides),
and high blood pressure constitute the metabolic
syndrome, a major risk factor for heart disease
and stroke.
Excess fat at the waist has been linked to several
other disorders as well. A European study of
nearly 500,000 women and men found that, for
women, a waist-to-hip ratio above 0.85 was associated
with a 52% increase in colorectal cancer risk.
A long-running community study on atherosclerosis
conducted by researchers at Wake Forest University
found that even among normal-weight people, those
with higher waist-to-hip ratios had just as much
difficulty as those with higher BMIs in carrying
out various activities of daily living, such
as getting in and out of bed and performing household
chores.
A larger waist measurement also predicts the
development of high blood pressure, regardless
of total body fat, according to a 10-year study
of Chinese adults published in the August 2006 American
Journal of Hypertension. Finally, a study
presented at the 2005 annual meeting of the Society
for Neuroscience found that older people with
bigger bellies had worse memory and less verbal
fluency, even after taking diabetes into account.
Now for the good news
So what can we do about tubby tummies? A lot,
it turns out. The starting point for bringing
weight under control, in general, and combating
abdominal fat, in particular, is regular moderate-intensity
physical activity — at least 30 minutes
per day (and perhaps up to 60 minutes per day)
to control weight. In a study comparing sedentary
adults with those exercising at different intensities,
researchers at Duke University Medical Center
found that the non-exercisers experienced a nearly
9% gain in visceral fat after six months. Subjects
who exercised the equivalent of walking or jogging
12 miles per week put on no visceral fat, and
those who exercised the equivalent of jogging
20 miles per week lost both visceral and subcutaneous
fat.
Strength training (exercising with weights)
may also help fight abdominal fat. A University
of Pennsylvania study followed overweight or
obese women, ages 24–44, for two years.
Compared to participants who received only advice
about exercise, those given an hour of weight
training twice a week reduced their proportion
of body fat by nearly 4% — and were more
successful in keeping off visceral fat.
Spot exercising, such as doing sit-ups, can
tighten abdominal muscles, but it won’t
get at visceral fat.
Diet is also important. Pay attention to portion
size, and emphasize complex carbohydrates (fruits,
vegetables, and whole grains) and lean protein
over simple carbohydrates such as white bread,
refined-grain pasta, and sugary drinks. Replacing
saturated fats and trans fats with polyunsaturated
fats can also help. But drastically cutting calories
is not a good diet strategy, because it can force
the body into starvation mode, slowing metabolism
and paradoxically causing it to store fat more
efficiently later on.
Scientists hope to develop drug treatments that
target abdominal fat. For example, studies of
the weight-loss medication sibutramine (Meridia),
which was approved in 1997, have shown that the
drug’s greatest effects are on visceral
fat. Rimonabant (Acomplia) — not yet FDA-approved — is
the first of a new class of drugs that block
a receptor in the brain that increases appetite.
Acomplia has been shown to modestly reduce the
accumulation of fat at the waist.
Because levels of the hormone dehydroepiandrosterone,
better known as DHEA, decline with age, many
people believe that DHEA supplementation can
reverse age-related changes, including increased
abdominal fat. DHEA is converted in the body
to testosterone and estrogen and regulates various
functions. Some studies have linked DHEA to longevity
in animals and people, and others have linked
it to modest health benefits. But the results
of a two-year randomized trial published in the
Oct. 19, 2006, New England Journal of Medicine showed
that DHEA had no effect on aging markers, including
body-composition measurements, in women and men
ages 60 and over.
For now, experts stress that lifestyle, especially
exercise, is the very best way to fight visceral
fat.
(This article was first printed in the December
2006 issue of the Harvard Women’s
Health Watch. For more information or to
order, please go to http://www.health.harvard.edu/womens.)
|
|